Cellulose Sulfate and HIV Transmission Among Women

CONRAD

Status and phase

Terminated

Phase 3

Conditions

HIV Infection

Treatments

Drug: Cellulose Sulfate gel (6%)

Study type

Interventional

Funder types

Other

Other U.S. Federal agency

Identifiers

NCT00153777

C03-090

Details and patient eligibility

About

The purpose of the study is to determine the effect of cellulose sulfate on the transmission of HIV to women via vaginal intercourse. The secondary objectives are the effect on the transmission of gonorrhea and chlamydia via the same route.

The study hypothesis is that there will be no effect.

Full description

Despite the availability of an effective HIV prevention method, i.e. the condom, the epidemic continues growing. There is thus an urgent need for additional HIV prevention methods. One of the possibilities is the use of microbicides, i.e. chemical products which may be used in the vagina or rectum with the potential to prevent HIV infection.

Cellulose sulfate is an HIV entry inhibitor with an in vitro effect on N. gonorrhoeae (NG) and C. trachomatis (CT) and other sexually transmitted organisms.

The study assess its effect on the vaginal transmission of HIV, NG and CT among women at high risk of heterosexual STI infection (defined as having had more than two partners in the last three months and an average of three sexual acts per week).

The study is randomized, triple-blinded, placebo controlled.

Enrollment

1,428 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

at least 18 years old
an average of at least three vaginal sex acts per week, at least three different partners in the last three months, expecting to continue this behavior
HIV negative
willing and able to comply with the protocol

Exclusion criteria